Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Diseases of the Thyroid

Free Subscription Articles published in Eur Thyroid J Retrieve available abstracts of 234 articles: HTML format

Single Articles

October 2026
1. GU H, Li C, Luo Y, Liu Y, et al
   The efficacy and safety of microwave ablation in benign large thyroid nodules (>/=4 cm).
   Eur Thyroid J. 2026;15:ETJ260013.
   PubMed     Abstract available
   
   
   
2. KUHLEN M, Naviglio S, Hirtz R, Virgone C, et al
   Approaches to thyroid nodules in paediatric cancer predisposition syndromes.
   Eur Thyroid J. 2026;15:ETJ260100.
   PubMed     Abstract available
   
   
   
3. NGUYEN LTT, Glover A, Gild M, Bullock M, et al
   TERT reactivation in thyroid cancer: mechanisms, clinical implications, and therapeutic opportunities.
   Eur Thyroid J. 2026;15:ETJ260068.
   PubMed     Abstract available
   
   
   
4. VAN OTZEL RP, Somers S, Narinx N, Nyamaah J, et al
   Primary thyroid dysfunction and changes in the gonadal axis and SHBG in adult men: a prospective cohort study.
   Eur Thyroid J. 2026;15:ETJ260111.
   PubMed     Abstract available
   
   
   
5. GARCIA-REGAL C, Quinones-Silva J, Brox-Torrecilla N, Martinez-Lorca A, et al
   Outcomes of patients with low-risk differentiated thyroid cancer with an excellent response to initial therapy.
   Eur Thyroid J. 2026;15:ETJ260223.
   PubMed     Abstract available
   
   
   August 2026
6. CROCE L, Chiardi I, Marchiselli Dell'Innocenti SA, Parisi R, et al
   Obesity-related thyroid reflections: from weight gain to weight loss.
   Eur Thyroid J. 2026;15:ETJ260082.
   PubMed     Abstract available
   
   
   
7. RODRIGUES MARCZYK V, Wang JR
   Single-cell RNA sequencing: a powerful tool to study heterogeneity in papillary and anaplastic thyroid carcinoma.
   Eur Thyroid J. 2026;15:ETJ250141.
   PubMed     Abstract available
   
   
   
8. CHAIB S, Castellnou S, Keniza T, Daru E, et al
   Estimation of the delay for resumption of breastfeeding after 131-iodine therapy by milk radioactivity measurement.
   Eur Thyroid J. 2026;15:ETJ260012.
   PubMed     Abstract available
   
   
   
9. YU B, Li X, Mei F, Huang J, et al
   Optimizing frozen section sampling for thyroid follicular neoplasms through intraoperative ultrasound guidance.
   Eur Thyroid J. 2026;15:ETJ260040.
   PubMed     Abstract available
   
   
   
10. VANCAUWENBERGH F, Decallonne B, Rochtus AM
    The effect of iodinated contrast media on thyroid (dys)function in children.
    Eur Thyroid J. 2026;15:ETJ260036.
    PubMed     Abstract available
    
    
    
11. TAYLOR P, Gibb F, Medici M, Parekh D, et al
    Management of endocrine emergencies: joint consensus statement for management of myxoedema coma.
    Eur Thyroid J. 2026;15:ETJ260044.
    PubMed     Abstract available
    
    
    
12. DASER A, Gulbins A, Horstmann M, Kalisch J, et al
    TNFalpha drives disease-specific chemokine networks and orbital tissue remodeling in a preclinical model of thyroid eye disease.
    Eur Thyroid J. 2026;15:ETJ250407.
    PubMed     Abstract available
    
    
    
13. TAYLOR P, Okosieme O, Effraimidis G, Gibb F, et al
    Management of thyroid emergencies: joint consensus statement on management of thyroid storm.
    Eur Thyroid J. 2026;15:ETJ260043.
    PubMed     Abstract available
    
    
    
14. DOMBREE MS, Sloot Y, Hugen N, Voorham QJ, et al
    Prevalence and outcome of metastases to the thyroid gland: a nationwide database study.
    Eur Thyroid J. 2026;15:ETJ250307.
    PubMed     Abstract available
    
    
    
15. DI MARCO T, Vergaro D, Mazzoni M, Mazzoleni B, et al
    COPZ1 depletion induces cell death through different mechanisms in in vitro murine models of thyroid cancer.
    Eur Thyroid J. 2026;15:ETJ250408.
    PubMed     Abstract available
    
    
    
16. NORUM WIGH IM, Karmisholt J, Vestergaard P, Andersen S, et al
    Thyroid disease in pregnancy and the risk of venous thromboembolism: a Danish nationwide cohort study.
    Eur Thyroid J. 2026;15:ETJ260154.
    PubMed     Abstract available
    
    
    June 2026
17. TALPACCI E, Macera M, Maida G, Morelli S, et al
    Real-world efficacy of lenvatinib/pembrolizumab combination in anaplastic thyroid carcinoma: case series from two Italian referral centers.
    Eur Thyroid J. 2026;15:ETJ250301.
    PubMed     Abstract available
    
    
    
18. ZWANZIGER D, Kowall B, Klose JM, Schmidt B, et al
    Thyroid hormone therapy in a population cohort over two decades indicates persistent overtreatment.
    Eur Thyroid J. 2026;15:ETJ250259.
    PubMed     Abstract available
    
    
    
19. ALVES-JUNIOR PAG, Araujo ML, Neto PN, Valverde P, et al
    Assessing the sodium-iodide symporter (NIS) in pediatric differentiated thyroid carcinoma.
    Eur Thyroid J. 2026;15:ETJ250237.
    PubMed     Abstract available
    
    
    
20. KAMPEL L, Dorman A, Trejo LL, Krol K, et al
    Pathologic and radiologic response to neoadjuvant therapy in advanced differentiated thyroid cancer.
    Eur Thyroid J. 2026;15:ETJ250394.
    PubMed     Abstract available
    
    
    
21. PETERS C, Wood C, Law JM, Stevens C, et al
    Retrospective, multicentre evaluation of central congenital hypothyroidism in the UK.
    Eur Thyroid J. 2026;15:ETJ260014.
    PubMed     Abstract available
    
    
    
22. BONDET DE LA BERNARDIE S, Bernier MO, Buffet C, Lussey-Lepoutre C, et al
    Salivary and lacrimal disorders in patients treated with radioiodine for differentiated thyroid cancer.
    Eur Thyroid J. 2026;15:ETJ250402.
    PubMed     Abstract available
    
    
    
23. PICCARDO A, Fiz F, Bottoni G, Treglia G, et al
    Recurrence risk of differentiated thyroid cancer treated with total or hemithyroidectomy: systematic review and meta-analysis.
    Eur Thyroid J. 2026;15:ETJ260060.
    PubMed     Abstract available
    
    
    
24. WANG L, Zhang L, Chen J, Wang D, et al
    CD8+ T cells in Hashimoto's thyroiditis-associated papillary thyroid carcinoma.
    Eur Thyroid J. 2026;15:ETJ250365.
    PubMed     Abstract available
    
    
    
25. CHANGOER P, van Houten P, Ceruti D, van Engen-van Grunsven I, et al
    Clinical actionability of molecular testing in advanced thyroid cancer: a real-world cohort study.
    Eur Thyroid J. 2026;15:ETJ260074.
    PubMed     Abstract available
    
    
    
26. DIEZ JJ, Anda E, Alcazar V, Galofre JC, et al
    Improved adequacy of levothyroxine treatment in low-risk differentiated thyroid cancer using the 2025 ATA criteria: a multicenter real-world analysis of 1,016 patients.
    Eur Thyroid J. 2026;15:ETJ260066.
    PubMed     Abstract available
    
    
    April 2026
27. QUENET M, Leroux S, Bendavid C, Saade MB, et al
    Newborn screening for congenital hypothyroidism in France: a study of current professional practices.
    Eur Thyroid J. 2026;15:ETJ250246.
    PubMed     Abstract available
    
    
    
28. TAMMELIN K, Holmberg M, Lindo A, Johansson B, et al
    Brain fatigue in Graves' disease: symptoms and presentation of a possible mechanism at the cellular level.
    Eur Thyroid J. 2026;15:ETJ250172.
    PubMed     Abstract available
    
    
    
29. MAHER M, McEvoy R, Farnan V, Lawless S, et al
    Plasma exchange aids thyroidectomy in refractory amiodarone-induced thyrotoxicosis, despite variable biochemical responses.
    Eur Thyroid J. 2026;15:ETJ250351.
    PubMed     Abstract available
    
    
    
30. DE OLIVEIRA MMB, Ward LS, Cury AN, Scalissi NM, et al
    Risk stratification and long-term monitoring in pediatric thyroid cancer: predictive markers for disease persistence.
    Eur Thyroid J. 2026;15:ETJ250236.
    PubMed     Abstract available
    
    
    
31. RODOLFI S, Vannucchi GM, Perrino M, Colombo C, et al
    High-dose intravenous methylprednisolone is effective in subacute thyroiditis unresponsive to oral steroids.
    Eur Thyroid J. 2026;15:ETJ250346.
    PubMed     Abstract available
    
    
    
32. EFFRAIMIDIS G, Kasotas A, Varsami S, Sazakli E, et al
    Promise and pitfalls of AI chatbots in complex decision-making for thyroid nodules and papillary thyroid cancer.
    Eur Thyroid J. 2026;15:ETJ250385.
    PubMed     Abstract available
    
    
    
33. KIYOTA N, Tahara M, Imai H, Takahashi S, et al
    Health-related quality of life with encorafenib plus binimetinib for BRAF V600E thyroid cancer.
    Eur Thyroid J. 2026;15:ETJ250273.
    PubMed     Abstract available
    
    
    
34. ZHAI L, Yin Y, Chen Y, Liang W, et al
    Habitat imaging based on water-fat separation for interpreting extraocular muscle heterogeneity in thyroid eye disease.
    Eur Thyroid J. 2026;15:ETJ250366.
    PubMed     Abstract available
    
    
    
35. FREY S, Volteau C, Lasolle H, Caillard C, et al
    Major adverse cardiac events in patients with amiodarone-induced thyrotoxicosis undergoing thyroidectomy: a multicenter study.
    Eur Thyroid J. 2026;15:ETJ250292.
    PubMed     Abstract available
    
    
    
36. WANG Z, Zhang W, Xie Y, Zhang D, et al
    Suspected track-site seeding as an isolated deep SH-SCM papillary thyroid carcinoma lesion years after TOETVA.
    Eur Thyroid J. 2026;15:ETJ250384.
    PubMed     Abstract available
    
    
    
37. SREEDHAR H, Delingette H, Lajoinie GPR, Ghanassia E, et al
    Study of French inter-expert variability in thyroid nodule ultrasound.
    Eur Thyroid J. 2026;15:ETJ260059.
    PubMed     Abstract available
    
    
    
38. JIAN L, Ou Q, Xia T, Tang G, et al
    Predictive value of baseline thyroid autoantibody titers for ICI-associated thyroid adverse events in cancer.
    Eur Thyroid J. 2026;15:ETJ260017.
    PubMed     Abstract available
    
    
    
39. WANG J, Mao Y, Xuan Z, Li Z, et al
    Preliminary study on ketone body metabolism in anaplastic thyroid cancer.
    Eur Thyroid J. 2026;15:ETJ250305.
    PubMed     Abstract available
    
    
    March 2026
40. NEWMAN C, Saqlain M, Mohammed IA, Bell D, et al
    Iopanoic acid rapidly restores euthyroidism in refractory thyrotoxicosis pre-thyroidectomy: a retrospective study.
    Eur Thyroid J. 2026;15:ETJ250350.
    PubMed     Abstract available
    
    
    February 2026
41. JELLOUL E, Lomre M, Kleynen P, Sitoris G, et al
    Low FT4 levels in early pregnancy are associated with higher insulin therapy need in women with gestational diabetes mellitus.
    Eur Thyroid J. 2026;15:ETJ250206.
    PubMed     Abstract available
    
    
    
42. THOMAZ DMD, Rocha WG, Albuquerque JC, Viana AOR, et al
    Tumor-informed liquid biopsy for monitoring thyroid cancer: a proof-of-concept study.
    Eur Thyroid J. 2026;15:ETJ250255.
    PubMed     Abstract available
    
    
    
43. MARCHAND JG, Bienvenu-Perrard M, Rouxel A, Ghander C, et al
    Can back-wall cystic figures of thyroid nodules predict benignity?
    Eur Thyroid J. 2026;15:ETJ250243.
    PubMed     Abstract available
    
    
    
44. WANG J, Chen D, Zhang J, Han X, et al
    Network toxicology and Mendelian randomization reveal pathogenic factors of monoethyl phthalate-induced thyroid cancer.
    Eur Thyroid J. 2026;15:ETJ250198.
    PubMed     Abstract available
    
    
    
45. MATURI R, Esposito M, Coppes RP, De Vita G, et al
    lncRNAs: a new generation of targets and biomarkers in thyroid cancer.
    Eur Thyroid J. 2026;15:ETJ250290.
    PubMed     Abstract available
    
    
    
46. CANBERK S, Isaza A, Bojarsky M, Simplicio M, et al
    The influence of age-independent somatic driver alterations on clinical outcomes in paediatric and young adult thyroid cancer.
    Eur Thyroid J. 2026;15:ETJ250310.
    PubMed     Abstract available
    
    
    
47. KIM J, Lee J, Ha J, Kwon O, et al
    Artificial intelligence-assisted risk stratification of thyroid nodules with atypia of undetermined significance.
    Eur Thyroid J. 2026;15:ETJ250268.
    PubMed     Abstract available
    
    
    
48. DUNTAS LH
    The caprices of a trace element: selenium's considerable effects on Hashimoto's thyroiditis, though few on Graves' disease.
    Eur Thyroid J. 2026;15:ETJ260009.
    PubMed     Abstract available
    
    
    
49. CERUTI D, Bonenkamp HJ, Colombo C, Gotthardt M, et al
    Clinical presentation and outcomes of medullary thyroid cancer in two European countries: impact of diagnostic strategies.
    Eur Thyroid J. 2026;15:ETJ250381.
    PubMed     Abstract available
    
    
    
50. SALVI M
    What has changed in thyroid eye disease in the last five years (2020-2025).
    Eur Thyroid J. 2026;15:ETJ250363.
    PubMed     Abstract available
    
    
    
51. YEO CT, Wu J, Ghaznavi S, Stewardson P, et al
    Impact of reflexive preoperative molecular testing for indeterminate nodules on lobectomy and completion thyroidectomy rates.
    Eur Thyroid J. 2026;15:ETJ250189.
    PubMed     Abstract available
    
    
    January 2026
52. SASAKI T, Kihara M, Fujishima M, Masuoka H, et al
    Clinical predictors of TRAb decline after total thyroidectomy in patients with Graves' disease.
    Eur Thyroid J. 2026;15:ETJ250284.
    PubMed     Abstract available
    
    
    
53. VOLZKE H, Henck V, Ittermann T, Pendt P, et al
    EUthyroid2: The next step towards the elimination of iodine deficiency and preventable iodine-related disorders in Europe and beyond.
    Eur Thyroid J. 2026;15:ETJ250335.
    PubMed     Abstract available
    
    
    
54. CRAMON PK, Winther KH, Boesen VB, Larsen CB, et al
    Selenium supplementation in individuals with newly diagnosed Graves' hyperthyroidism: a double-blind, multi-centre RCT.
    Eur Thyroid J. 2026;15:ETJ250264.
    PubMed     Abstract available
    
    
    
55. BEN HAMOU A, Marchand JG, Poiree S, Ghander C, et al
    Predictors of retreatment after radiofrequency ablation of benign thyroid nodules: role of pre-treatment growth rate and viable volume.
    Eur Thyroid J. 2026;15:ETJ250254.
    PubMed     Abstract available
    
    
    December 2025
56. HUANG NS, Chen JY, Wei WJ, Hu JQ, et al
    Personalized treatment of 95 poorly differentiated thyroid cancer/anaplastic thyroid cancer in 2019-2023.
    Eur Thyroid J. 2025;14:e240371.
    PubMed     Abstract available
    
    
    
57. MASAKI C, Chiba T, Baba S, Moriya K, et al
    Nuclear STAT3 expression is associated with favorable prognosis in papillary thyroid carcinoma.
    Eur Thyroid J. 2025;14:e250080.
    PubMed     Abstract available
    
    
    
58. RODRIGUES L, Sousa Martins R, Maximo V, Soares P, et al
    DICER1 and DGCR8 in thyroid tumorigenesis: miRNA biogenesis and histopathologic diversity.
    Eur Thyroid J. 2025;14:e250188.
    PubMed     Abstract available
    
    
    
59. VAN GEEST FS, Liao W, Voorhoeve PG, Leen WG, et al
    Extreme resistance to thyroid hormone caused by a novel mosaic thyroid hormone receptor beta mutation.
    Eur Thyroid J. 2025;14:e250092.
    PubMed     Abstract available
    
    
    
60. YAMAZAKI H, Sugino K, Katoh R, Matsuzu K, et al
    Dynamic risk stratification in patients with follicular thyroid carcinoma treated with lobectomy.
    Eur Thyroid J. 2025;14:e250154.
    PubMed     Abstract available
    
    
    
61. DOWELL N, Begum S, Muzaffar J, Boelaert K, et al
    Comparing the diagnostic accuracy of Afirma GSC to ThyroSeq V3 in cytologically indeterminate thyroid nodules.
    Eur Thyroid J. 2025;14:e250296.
    PubMed     Abstract available
    
    
    
62. BARTALENA L, Gallo D, Kahaly GJ, Marino M, et al
    Comparison of the 2021 EUGOGO guidelines and the 2022 ATA/ETA consensus statement for the management of Graves' orbitopathy.
    Eur Thyroid J. 2025;14:e250318.
    PubMed     Abstract available
    
    
    
63. ZHAO R, Su Z, Wan Z, Qiao P, et al
    MAPK13 promotes the progression of papillary thyroid cancer.
    Eur Thyroid J. 2025;14:e250083.
    PubMed     Abstract available
    
    
    
64. RAVI R, Niskanen A, Reeve MP, Makkonen K, et al
    Very-early-onset autoimmune hypothyroidism: a report of two cases with STAT3 gain-of-function variant.
    Eur Thyroid J. 2025;14:e250260.
    PubMed     Abstract available
    
    
    
65. HU R, Tang S, Liu X, Liu Z, et al
    Predicting dysthyroid optic neuropathy in moderate-to-severe thyroid eye disease: a clinically applicable nomogram.
    Eur Thyroid J. 2025;14:e250226.
    PubMed     Abstract available
    
    
    
66. GREGORIO ARNAUT LIMA E, Silveira Marcello K, Viana A, Knabben Ortellado D, et al
    External validation of a microRNA thyroid classifier: a real-world prospective study.
    Eur Thyroid J. 2025;14:e250105.
    PubMed     Abstract available
    
    
    
67. TELITI M, Grillini B, Chiardi I, Magri F, et al
    Case series of de novo occurrence of Graves' disease following thermal ablation for benign thyroid nodules: an uncommon event that should be considered.
    Eur Thyroid J. 2025;14:e250205.
    PubMed     Abstract available
    
    
    
68. RIESCO-EIZAGUIRRE G
    BRAF V600E in thyroid cancer: navigating prognostic uncertainty and therapeutic opportunity.
    Eur Thyroid J. 2025;14:e250225.
    PubMed     Abstract available
    
    
    
69. URSEM SR, den Elzen WPJ, van den Berg JM, Boelen A, et al
    Natural course of subclinical hyperthyroidism in primary care in the Netherlands.
    Eur Thyroid J. 2025;14:e250142.
    PubMed     Abstract available
    
    
    October 2025
70. JAGER EC, Sondorp LHJ, Maturi R, Antunes IF, et al
    Patient-derived medullary thyroid cancer organoids: a potential model for mechanistic studies on diagnostics and therapy.
    Eur Thyroid J. 2025;14:e240405.
    PubMed     Abstract available
    
    
    
71. VIRGINIA C, Antonio M, Valeria B, Alessandro P, et al
    Multifocality and bilaterality in medullary thyroid cancer: basis for a proof-of-concept safety of lobectomy.
    Eur Thyroid J. 2025;14:e250074.
    PubMed     Abstract available
    
    
    
72. QUATTROCHI F, Grunenwald S, Caron P
    Apalutamide treatment and refractory hypothyroidism: effects of apalutamide on levothyroxine metabolism.
    Eur Thyroid J. 2025;14:e250185.
    PubMed     Abstract available
    
    
    
73. TOFT KRISTENSEN T, Plaschke CC, Fog Lomholt A, Holst Hahn C, et al
    Prevalence of endogenous normal thyroid function 3 years after hemithyroidectomy for differentiated thyroid cancer.
    Eur Thyroid J. 2025;14:e240282.
    PubMed     Abstract available
    
    
    
74. LEE ACH, Kahaly GJ
    Unravelling the pathogenic mechanisms in Graves' orbitopathy.
    Eur Thyroid J. 2025;14:e250200.
    PubMed     Abstract available
    
    
    
75. LI GH, Tang CM, Li RS, Ge GM, et al
    Twenty-year trend of thyrotoxicosis and thyrotoxic periodic paralysis: a population-based cohort study.
    Eur Thyroid J. 2025;14:e250220.
    PubMed     Abstract available
    
    
    
76. CIAPPUCCINI R, Saguet-Rysanek V, Bompain PA, Balosso J, et al
    NSD3::NUTM1 fusion evidenced on RNA sequencing in poorly differentiated thyroid cancer: a report of two cases.
    Eur Thyroid J. 2025;14:e250100.
    PubMed     Abstract available
    
    
    
77. KATOH H, Okamoto R, Ozawa Y, Tokito T, et al
    Lenvatinib as an urgent initial therapy in thyroid cancer with remarkable laryngotracheal invasion.
    Eur Thyroid J. 2025;14:e250212.
    PubMed     Abstract available
    
    
    
78. PITICCHIO T, Piombino E, Galeano F, Volpe S, et al
    Minimal or absent tumor desmoplasia predicts lower recurrence risk in papillary thyroid carcinoma.
    Eur Thyroid J. 2025;14:e250239.
    PubMed     Abstract available
    
    
    
79. LAI ST, Bojarsky M, Baran J, Isaza A, et al
    pT1a papillary thyroid carcinomas in pediatric patients.
    Eur Thyroid J. 2025;14:e250119.
    PubMed     Abstract available
    
    
    
80. VAN DEN BRUEL A, Drieskens P, Van Haecke H, De Geeter F, et al
    Graves' disease in ectopic thyroid tissue: a scoping review and a case study.
    Eur Thyroid J. 2025;14:e250135.
    PubMed     Abstract available
    
    
    
81. CALAFATO G, Di Paola FJ, De Leo A, Maloberti T, et al
    Somatic genetic alterations in the development and progression in thyroid tumors of follicular cells.
    Eur Thyroid J. 2025;14:e250104.
    PubMed     Abstract available
    
    
    August 2025
82. WANG J, Teng D, Yang K, Liu S, et al
    Long-term exposure to PM1 and thyroid diseases in China.
    Eur Thyroid J. 2025;14:e250106.
    PubMed     Abstract available
    
    
    
83. CERUTI D, Ottevanger PB, De Leo S, Bonenkamp HJ, et al
    Differentiated thyroid cancer in two European referral centres: impact of different diagnostic and therapeutic strategies.
    Eur Thyroid J. 2025;14:e250161.
    PubMed     Abstract available
    
    
    
84. RIOS-MORRIS E, Tientcheu Ngaffi VI, Costagliola S, Romitti M, et al
    NOVEL INSIGHTS IN ADVANCED THYROID CARCINOMA: FROM MECHANISMS TO TREATMENTS: Development of 3D organoid models to study aggressive thyroid cancers.
    Eur Thyroid J. 2025;14:e240392.
    PubMed     Abstract available
    
    
    
85. TAPROGGE J, Murray I, Sharman H, Gape P, et al
    Predictive factors of radioiodine ablation success: results from a MEDIRAD prospective clinical study for thyroid cancer.
    Eur Thyroid J. 2025;14:e250097.
    PubMed     Abstract available
    
    
    
86. ZABLOTSKA LB, McConnell RJ, Rozhko AV, O'Kane P, et al
    Validation of established thyroid ultrasound volume norms in a Chernobyl cohort.
    Eur Thyroid J. 2025;14:e250085.
    PubMed     Abstract available
    
    
    
87. XU S, Peng Y, Li X, Li H, et al
    TSHR in thyroid cancer: bridging biological insights to targeted strategies.
    Eur Thyroid J. 2025;14:e240369.
    PubMed     Abstract available
    
    
    
88. TRIMBOLI P, Makovac P, Colombo A, Ruinelli L, et al
    Analysis of FNAC indication in thyroid nodules assessed as low risk according to various TIRADSs.
    Eur Thyroid J. 2025;14:e250113.
    PubMed     Abstract available
    
    
    
89. LUNDGAARD MH, Bruun NH, Andersen S, Andersen SL, et al
    Birth weight and placental weight in children born to mothers with hypothyroidism.
    Eur Thyroid J. 2025;14:e250111.
    PubMed     Abstract available
    
    
    
90. RYSKA A, Capdevila J, Dettmer MS, Elisei R, et al
    Molecular predictive biomarker testing in advanced thyroid cancer - a European consensus.
    Eur Thyroid J. 2025;14:e250024.
    PubMed     Abstract available
    
    
    
91. KASAHARA T
    The relationship between levothyroxine dosage and free thyroxine levels in hypothyroid patients: a large retrospective study.
    Eur Thyroid J. 2025;14:e240388.
    PubMed     Abstract available
    
    
    
92. MEGIER C, Luton D, Stoupa A
    50 YEARS OF NEWBORN SCREENING FOR CONGENITAL HYPOTHYROIDISM: EVOLUTION OF INSIGHTS IN ETIOLOGY, DIAGNOSIS AND MANAGEMENT: Management during pregnancy and long-term outcomes of adult patients with congenital hypothyroidism.
    Eur Thyroid J. 2025;14:e250125.
    PubMed     Abstract available
    
    
    
93. STAN MN, Dosiou C
    The evolving therapeutic landscape of Graves' disease in adults: present and future.
    Eur Thyroid J. 2025;14:e250078.
    PubMed     Abstract available
    
    
    
94. CENTANNI M, Duntas L, Feldt-Rasmussen U, Koehrle J, et al
    ETA guidelines for the use of levothyroxine sodium preparations in monotherapy to optimize the treatment of hypothyroidism.
    Eur Thyroid J. 2025;14:e250123.
    PubMed     Abstract available
    
    
    
95. KUHLEN M, Kunstreich M, Eilsberger F, Lorenz K, et al
    Risk-adapted therapy in pediatric thyroid cancer: initial experience from a national reference program by the MET group.
    Eur Thyroid J. 2025;14:e250035.
    PubMed     Abstract available
    
    
    
96. VINCENZI G, Petralia IT, Abbate M, Vigone MC, et al
    50 YEARS OF NEWBORN SCREENING FOR CONGENITAL HYPOTHYROIDISM: EVOLUTION OF INSIGHTS IN ETIOLOGY, DIAGNOSIS AND MANAGEMENT: Transient or permanent congenital hypothyroidism: from milestones to current and future perspectives.
    Eur Thyroid J. 2025;14:e250019.
    PubMed     Abstract available
    
    
    June 2025
97. KYRIACOU A, Vryza P, Kyriacou A, Picolos M, et al
    Severity of thyrotoxicosis is a risk factor for excessive weight gain in treated hyperthyroidism.
    Eur Thyroid J. 2025;14:e240373.
    PubMed     Abstract available
    
    
    
98. GRIXTI L, Fisher H, Priestley J, McMullan C, et al
    Prevalence and severity of fatigue in treated hypothyroidism: results of a UK survey.
    Eur Thyroid J. 2025;14:e250044.
    PubMed     Abstract available
    
    
    
99. SESTI F, Feola T, Dolce P, Guarnotta V, et al
    Role of the calcium stimulation test in diagnosing medullary thyroid cancer: is it adequate to achieve a diagnosis in both sexes? An individual patient data meta-analysis.
    Eur Thyroid J. 2025;14:e240347.
    PubMed     Abstract available
    
    
    
100. KARIMI AH, Zeng PY, Cecchini M, Barrett JW, et al
     NOVEL INSIGHTS IN ADVANCED THYROID CARCINOMA: FROM MECHANISMS TO TREATMENTS: Molecular insights into the origin, biology, and treatment of anaplastic thyroid carcinoma.
     Eur Thyroid J. 2025;14:e250057.
     PubMed     Abstract available
     
     
     
101. PASCHKE R, Ghaznavi S, Imran SA, Jacquier J, et al
     Follow-up and transition of care for low recurrence risk thyroid cancer patients in Canada.
     Eur Thyroid J. 2025;14:e250072.
     PubMed     Abstract available
     
     
     
102. PIEKIELKO-WITKOWSKA A, Duda MK, Boguslawska J, Mackiewicz U, et al
     The impact of autoimmune thyroid disease on cognitive and psychiatric disorders: focus on clinical, pre-clinical and molecular studies.
     Eur Thyroid J. 2025;14:e240406.
     PubMed     Abstract available
     
     
     
103. MANSO J, Muller I, Mian C
     Clinical management of alemtuzumab-induced autoimmune thyroid diseases: a narrative review.
     Eur Thyroid J. 2025;14:e250007.
     PubMed     Abstract available
     
     
     
104. CONDELLO V, Doerfler WR, Nikitski AV, Spagnolo DM, et al
     Alterations in gene expression associated with invasion of RAS-mutant thyroid tumors and their potential diagnostic and therapeutic utility.
     Eur Thyroid J. 2025;14:e250022.
     PubMed     Abstract available
     
     
     
105. LIU X, Cui L, Dong J, Ren J, et al
     Potential of bone marrow mesenchymal stem cells in iodine-induced autoimmune thyroiditis therapy.
     Eur Thyroid J. 2025;14:e240137.
     PubMed     Abstract available
     
     
     
106. NESET MT, Ulvik A, Lovas K, Laupsa-Borge J, et al
     Insight into the metabolic shifts in Graves' hyperthyroidism: a study of acylcarnitine and lipid profiles.
     Eur Thyroid J. 2025;14:e250004.
     PubMed     Abstract available
     
     
     
107. MORITANI S, Takenobu M, Yasunaga M, Fujii T, et al
     Usefulness of local therapy for distant metastases of differentiated thyroid cancer.
     Eur Thyroid J. 2025;14:e240237.
     PubMed     Abstract available
     
     
     
108. COSTE J, Mandereau-Bruno L, Bertagna X, Wemeau JL, et al
     Prevalence of treated hyper- and hypo-thyroidism and sociodemographic and geographic disparities in France in 2020.
     Eur Thyroid J. 2025;14:e250041.
     PubMed     Abstract available
     
     
     April 2025
109. GROB F, Lain S, Olivieri A
     Newborn screening for primary congenital hypothyroidism: past, present and future.
     Eur Thyroid J. 2025;14:e240358.
     PubMed     Abstract available
     
     
     
110. NYGAARD B, Jensen CZ, Jorsal M, Medici BR, et al
     Long-term outcomes of LT4/LT3 combination treatment for persistent hypothyroid symptoms.
     Eur Thyroid J. 2025;14:e240275.
     PubMed     Abstract available
     
     
     
111. URKEN ML, Brandwein-Weber M, Chai RL, Zafereo M, et al
     An anatomic checklist for accurate staging of grossly invasive thyroid cancer.
     Eur Thyroid J. 2025;14:e240289.
     PubMed     Abstract available
     
     
     
112. LI T, Gui Y, Cui X, Wu X, et al
     Comparison of short-term outcomes following minimally invasive (endoscopic/robotic) vs open thyroidectomy for patients with thyroid cancer.
     Eur Thyroid J. 2025;14:e240134.
     PubMed     Abstract available
     
     
     
113. YAMAZAKI H, Sugino K, Inoue K, Katoh R, et al
     Analysis of immediate 503 thyroid carcinoma deaths: trend of single institution in 2005-2024.
     Eur Thyroid J. 2025;14:e240368.
     PubMed     Abstract available
     
     
     
114. EFFRAIMIDIS G, Sazakli E, Karapanou O, Saltiki K, et al
     Active surveillance for low-risk papillary thyroid microcarcinoma: a web-survey on clinician readiness for change.
     Eur Thyroid J. 2025;14:e250013.
     PubMed     Abstract available
     
     
     
115. HIROMASA T, Wakabayashi H, Watanabe S, Yamase T, et al
     Enhancing radioactive iodine (RAI) incorporation in RAI-refractory differentiated thyroid cancer: current insights.
     Eur Thyroid J. 2025;14:e240319.
     PubMed     Abstract available
     
     
     
116. DIEZ JJ, Galofre JC
     Management of benign nodular thyroid disease: a nationwide survey of endocrine specialists in Spain.
     Eur Thyroid J. 2025;14:e240313.
     PubMed     Abstract available
     
     
     
117. STOUPA A, Carre A, Polak M, Szinnai G, et al
     Genetics of primary congenital hypothyroidism: three decades of discoveries and persisting etiological challenges.
     Eur Thyroid J. 2025;14:e240348.
     PubMed     Abstract available
     
     
     
118. CHAUDHURY N, Crasto W, Saravanan P, Patel V, et al
     Intramuscular and subcutaneous levothyroxine: success in treating refractory hypothyroidism.
     Eur Thyroid J. 2025;14:e250012.
     PubMed     Abstract available
     
     
     
119. NOWAK A, Podlewski J, Hubalewska-Dydejczyk A, Trofimiuk-Muldner M, et al
     The impact of insulin resistance on thyroid function and the prevalence of thyroid follicular nodular disease in pregnant women.
     Eur Thyroid J. 2025;14:e240317.
     PubMed     Abstract available
     
     
     
120. ELOMAA K, Spick M, Gan EH, Pearce SH, et al
     Variable hyperthyroidism outcomes related to different treatment regimens: an analysis of UK Biobank data.
     Eur Thyroid J. 2025;14:e240393.
     PubMed     Abstract available
     
     
     
121. SMOLDERS A, Kyrilli A, Constantinescu SM, Corvilain B, et al
     High-dose versus low-dose block-and-replace treatment for a first episode of Graves' disease.
     Eur Thyroid J. 2025;14:e250039.
     PubMed     Abstract available
     
     
     
122. LUGARESI M, Moneta C, Saruggia G, Dionigi G, et al
     Changing the paradigm: lobectomy for sporadic medullary thyroid cancer.
     Eur Thyroid J. 2025;14:e250040.
     PubMed     Abstract available
     
     
     
123. KIYOTA N, Koyama T, Sugitani I
     Anticancer drug therapy for anaplastic thyroid cancer.
     Eur Thyroid J. 2025;14:e240287.
     PubMed     Abstract available
     
     
     
124. TAN J, Ge J, Wei Z, Sun B, et al
     Nomogram to predict the prognostic value of tumor deposits for patients with papillary thyroid carcinoma.
     Eur Thyroid J. 2025;14:e240343.
     PubMed     Abstract available
     
     
     
125. MA Z, Mu R, Zhou Z, Hu Z, et al
     The mammalian acid chitinase promotes oncogenic properties of thyroid cancer cells through the JAK2/STAT3 pathway.
     Eur Thyroid J. 2025;14:e240311.
     PubMed     Abstract available
     
     
     
126. PULIANI G, Bianchini M, Giani C, Valerio L, et al
     Gender impact on safety and efficacy in lenvatinib treated patients with radioiodine-refractory differentiated thyroid cancer (GISEL study).
     Eur Thyroid J. 2025;14:e240386.
     PubMed     Abstract available
     
     
     February 2025
127. CROCE L, Ruggeri RM, Virili C, Cappelli C, et al
     Differences and analogies in thyroid cancer discovered incidentally or by thyroid related screening: A multicenter study.
     Eur Thyroid J. 2025;14:e240190.
     PubMed     Abstract available
     
     
     
128. ZHANG H, Wu S, Yang L, Fan C, et al
     Investigating factors influencing quality of life in thyroid eye disease: insight from machine learning approaches.
     Eur Thyroid J. 2025;14:e240292.
     PubMed     Abstract available
     
     
     
129. KIM MJ, Moon JH, Lee EK, Song YS, et al
     A national survey of physicians regarding active surveillance for low-risk thyroid cancer in Korea.
     Eur Thyroid J. 2025;14:e240281.
     PubMed     Abstract available
     
     
     
130. DEMETRIOU E, Economides A, Fokou M, Lamnisos D, et al
     Adiposity is associated with a higher number of thyroid nodules and worse fine-needle aspiration outcomes.
     Eur Thyroid J. 2025;14:e240176.
     PubMed     Abstract available
     
     
     
131. GRACA GM, Aguiar LR, De Lacerda L
     New diagnostic approach to central hypothyroidism after traumatic brain injury in children and adolescents.
     Eur Thyroid J. 2025;14:e240184.
     PubMed     Abstract available
     
     
     
132. POTONNIER W, Guillerm E, Bigorgne C, Ghander C, et al
     Performance of the AmpliSeq NGS panel in thyroid nodules with indeterminate cytology.
     Eur Thyroid J. 2025;14:e240160.
     PubMed     Abstract available
     
     
     
133. YAMAUCHI I, Yabe D
     Best practices in the management of thyroid dysfunction induced by immune checkpoint inhibitors.
     Eur Thyroid J. 2025;14:e240328.
     PubMed     Abstract available
     
     
     
134. LEE OW, Karyadi DM, Hartley SW, Zhou W, et al
     Somatic copy number deletion of chromosome 22q in papillary thyroid carcinoma.
     Eur Thyroid J. 2025;14:e240235.
     PubMed     Abstract available
     
     
     
135. PORCELLI T, Luongo C, Cerbone A, Di Luccio C, et al
     Did selective kinase inhibitors change the management of patients with radioiodine-refractory thyroid cancer?
     Eur Thyroid J. 2025;14:e240332.
     PubMed     Abstract available
     
     
     
136. CARDO C, Bernardo Santos R, Pinotti Pedro Miklos AB, Barbosa Jaconis S, et al
     The relationship between cholesterol levels and thyroid eye disease.
     Eur Thyroid J. 2025;14:e240133.
     PubMed     Abstract available
     
     
     
137. ARRIGONI M, Zwaveling-Soonawala N, LaFranchi SH, van Trotsenburg ASP, et al
     Newborn screening for congenital hypothyroidism: worldwide coverage 50 years after its start.
     Eur Thyroid J. 2025;14:e240327.
     PubMed     Abstract available
     
     
     
138. PICCARDO A, Fiz F, Righi S, Raffa S, et al
     [18F]Tetrafluoroborate, a new NIS PET/CT radiopharmaceutical: an overview focused on differentiated thyroid cancer.
     Eur Thyroid J. 2025;14:e240320.
     PubMed     Abstract available
     
     
     
139. LIU M, Tang J, Sun N, Xi C, et al
     Pleural metastases from differentiated thyroid cancer: clinical features and long-term outcomes.
     Eur Thyroid J. 2025;14:e240147.
     PubMed     Abstract available
     
     
     
140. DUTTA S, Knauf JA
     Development of animal models to study aggressive thyroid cancers.
     Eur Thyroid J. 2025;14:e240361.
     PubMed     Abstract available
     
     
     
141. BOELEN A, Heijboer AC
     Newborn screening and the screening laboratory: past, present and future.
     Eur Thyroid J. 2025;14:e240325.
     PubMed     Abstract available
     
     
     
142. VALDERRABANO P, Quinones Silva JB, Campos Mena S, Familiar Casado C, et al
     Evaluation of thyroid ultrasound reports' quality in the Community of Madrid, Spain.
     Eur Thyroid J. 2025;14:e240390.
     PubMed     Abstract available
     
     
     
143. GARRELFS MR, Mooij CF, Boelen A, van Trotsenburg ASP, et al
     Newborn screening for central congenital hypothyroidism: past, present and future.
     Eur Thyroid J. 2025;14:e240329.
     PubMed     Abstract available
     
     
     
144. PRASAI M, Lomre M, Jelloul E, Kleynen P, et al
     Higher prevalence of gestational diabetes in euthyroid women with thyroid autoimmunity who were expecting a female fetus.
     Eur Thyroid J. 2025;14:e240339.
     PubMed     Abstract available
     
     
     
145. KUHLEN M, Kunstreich M, Eilsberger F, Luster M, et al
     Pediatric differentiated thyroid carcinoma leading to fatal lung fibrosis.
     Eur Thyroid J. 2025;14:e240341.
     PubMed     Abstract available
     
     
     December 2024
146. RUCZ K, Hegedus L, Bonnema SJ, Frasoldati A, et al
     Echogenicity as a standalone nodule characteristic is not inferior to the TIRADS systems in the 10-20 mm nodule diameter range in patient selection for fine needle aspiration: a pilot study.
     Eur Thyroid J. 2024;13:e240149.
     PubMed     Abstract available
     
     
     
147. MARINO M, Rotondo Dottore G, Menconi F, Comi S, et al
     Role of genetics and epigenetics in Graves' orbitopathy.
     Eur Thyroid J. 2024;13:e240179.
     PubMed     Abstract available
     
     
     
148. PAUL J, Joseph A, Jebasingh F, More AR, et al
     Thyrotoxic periodic paralysis - a retrospective study from Southern India.
     Eur Thyroid J. 2024;13:e240164.
     PubMed     Abstract available
     
     
     
149. CARLQVIST J, Nyman U, Brandberg J, Nystrom HF, et al
     Effects of iodine contrast media on thyroid function - a prospective study.
     Eur Thyroid J. 2024;13:e240244.
     PubMed     Abstract available
     
     
     
150. FUJIKAWA M, Okamura K
     Graves' hyperthyroidism treated with potassium iodide: early response and after 2 years of follow-up.
     Eur Thyroid J. 2024;13:e240085.
     PubMed     Abstract available
     
     
     
151. ELGHAWY O, Barsouk A, Xu J, Chen S, et al
     Real word outcomes of cabozantinib therapy in poorly differentiated thyroid carcinoma.
     Eur Thyroid J. 2024;13:e240225.
     PubMed     Abstract available
     
     
     
152. CONDELLO V, Juhlin CC
     MicroRNA regulator gene mutations in thyroid follicular nodular disease and thyroid cancer: does it all come down to timing?
     Eur Thyroid J. 2024;13:e240298.
     PubMed     Abstract available
     
     
     October 2024
153. LEE HJ, Hah YS, Cheon SY, Won SJ, et al
     Decreased sirtuin 4 levels promote cellular proliferation and invasion in papillary thyroid carcinoma.
     Eur Thyroid J. 2024;13:e240079.
     PubMed     Abstract available
     
     
     
154. LEE HJ, Hah YS, Cheon SY, Won SJ, et al
     Decreased sirtuin 4 levels promote cellular proliferation and invasion in papillary thyroid carcinoma.
     Eur Thyroid J. 2024;13:e240079.
     PubMed     Abstract available
     
     
     
155. GAMBALE C, Prete A, Romei C, Celi A, et al
     Fluctuating obliterative bronchiolitis in RET-mutant medullary thyroid cancer patient treated with selpercatinib.
     Eur Thyroid J. 2024;13:e240189.
     PubMed     Abstract available
     
     
     
156. ITO Y, Miyauchi A
     Prognostic factors of papillary and follicular carcinomas based on pre-, intra-, and post-operative findings.
     Eur Thyroid J. 2024;13:e240196.
     PubMed     Abstract available
     
     
     
157. PARK H, Heo J, Ryu HJ, Kim MJ, et al
     The association between BMI and BRAFV600E mutation may differ by primary tumor size.
     Eur Thyroid J. 2024;13:e230255.
     PubMed     Abstract available
     
     
     
158. YAMAZAKI H, Sugino K, Katoh R, Matsuzu K, et al
     Management of follicular thyroid carcinoma.
     Eur Thyroid J. 2024;13:e240146.
     PubMed     Abstract available
     
     
     
159. DAVID K, Van Crombrugge P, Van der Biest AM, D'Hondt F, et al
     Apalutamide-induced severe hypothyroidism: case series and practice recommendations for thyroid management.
     Eur Thyroid J. 2024;13:e240158.
     PubMed     Abstract available
     
     
     
160. TSYBROVSKYY O, Sobrinho-Simoes M, Tallini G
     'Incidental thyroid cancer' is not synonymous with 'overdiagnosis'.
     Eur Thyroid J. 2024;13:e240283.
     PubMed    
     
     
     
161. COSME I, Figueiredo A, Pinheiro S, Leite V, et al
     Incidental thyroid cancer and overdiagnosis: response to Drs Tsybrovskyy, Sobrinho-Simoes, and Tallini.
     Eur Thyroid J. 2024;13:e240296.
     PubMed    
     
     
     
162. IMAI H, Watanabe N, Hirose R, Koshibu M, et al
     Subacute thyroiditis during pregnancy: clinical characteristics of seven cases.
     Eur Thyroid J. 2024;13:e240128.
     PubMed     Abstract available
     
     
     
163. ZHAO C, Sun Z, Wang S, Zhang J, et al
     IgG4 glycosylation contributes to the pathogenesis of IgG4 Hashimoto's thyroiditis via the complement pathway.
     Eur Thyroid J. 2024;13:e240156.
     PubMed     Abstract available
     
     
     August 2024
164. LAI KKH, Aljufairi FMAA, Sebastian JU, Wei Y, et al
     Epidemiology of thyroid-stimulating immunoglobulin in recent-onset symptomatic thyroid eye disease.
     Eur Thyroid J. 2024;13:e230129.
     PubMed     Abstract available
     
     
     
165. CHUNG CW, Kim K, Park SK, Ju DL, et al
     Selenium levels and their association with thyroid autoimmunity and severe preeclampsia in pregnancy: Insights from a prospective ideal breast milk cohort study.
     Eur Thyroid J. 2024;13:e240007.
     PubMed     Abstract available
     
     
     
166. ZHANG Z, Yu J, Rainer E, Hargitai L, et al
     The role of [18F]F-DOPA PET/CT in diagnostic and prognostic assessment of medullary thyroid cancer: a 15-year experience with 109 patients.
     Eur Thyroid J. 2024;13:e240089.
     PubMed     Abstract available
     
     
     
167. BARAN JA, Bojarsky M, Halada S, Ricarte-Filho JC, et al
     Low-invasive somatic oncogenes and lymph node metastasis in pediatric papillary thyroid cancer: implications for prophylactic central neck dissection.
     Eur Thyroid J. 2024;13:e230265.
     PubMed     Abstract available
     
     
     
168. LEONCINI A, Camponovo C, Paone G, Gamarra E, et al
     Risk of TIRADS-based inappropriate FNAC in autonomous thyroid nodules is clinically negligible.
     Eur Thyroid J. 2024;13:e240123.
     PubMed     Abstract available
     
     
     
169. MINALDI E, Cappagli V, Lorusso L, Valerio L, et al
     Hand-foot syndrome in sorafenib and lenvatinib treatment for advanced thyroid cancer.
     Eur Thyroid J. 2024;13:e240009.
     PubMed     Abstract available
     
     
     
170. PERSANI L, Rodien P, Moran C, Edward Visser W, et al
     2024 European Thyroid Association Guidelines on diagnosis and management of genetic disorders of thyroid hormone transport, metabolism and action.
     Eur Thyroid J. 2024;13:e240125.
     PubMed     Abstract available
     
     
     
171. HECHT F, Valerio L, Goncalves CFL, Harinquet M, et al
     A post-irradiation-induced replication stress promotes RET proto-oncogene breakage.
     Eur Thyroid J. 2024;13:e240028.
     PubMed     Abstract available
     
     
     
172. VAN HOUTEN P, Nagarajah J, Walraven JEW, Jaeger M, et al
     Digoxin treatment does not reinduce radioiodine uptake in radioiodine refractory non-medullary thyroid carcinoma.
     Eur Thyroid J. 2024;13:e240153.
     PubMed     Abstract available
     
     
     
173. ZHANG H, Wu S, Hu S, Fan X, et al
     Prediction models of intravenous glucocorticoids therapy response in thyroid eye disease.
     Eur Thyroid J. 2024;13:e240122.
     PubMed     Abstract available
     
     
     June 2024
174. COLOMBO C, Ceruti D, Succi M, De Leo S, et al
     Impact of systemic treatments for advanced thyroid cancer on the adrenal cortex.
     Eur Thyroid J. 2024;13:e230246.
     PubMed     Abstract available
     
     
     
175. SYED AR, Gorana A, Nohr E, Yuan XK, et al
     Predictors of radioiodine (RAI)-avidity restoration for NTRK fusion-positive RAI-resistant metastatic thyroid cancers.
     Eur Thyroid J. 2024;13:e230227.
     PubMed     Abstract available
     
     
     
176. FUGAZZOLA L, Deandrea M, Borgato S, Dell'Acqua M, et al
     Radiofrequency ablation is an effective treatment for Bethesda III thyroid nodules without genetic alterations.
     Eur Thyroid J. 2024;13:e240020.
     PubMed     Abstract available
     
     
     
177. CIRELLO V, Lugaresi M, Moneta C, Dufour P, et al
     Thyroid cancer and endocrine disruptive chemicals: a case-control study on per-fluoroalkyl substances and other persistent organic pollutants.
     Eur Thyroid J. 2024;13:e230192.
     PubMed     Abstract available
     
     
     
178. TANG MOLLEHAVE L, Knudsen N, Linneberg A, Bulow Pedersen I, et al
     The Danish investigation on iodine intake and thyroid disease (DanThyr): history and implications.
     Eur Thyroid J. 2024;13:e230230.
     PubMed     Abstract available
     
     
     
179. CHEN J, Li C, Teng W, Shan Z, et al
     A Chinese survey of clinical practice on the management of thyroid eye disease.
     Eur Thyroid J. 2024;13:e230269.
     PubMed     Abstract available
     
     
     
180. MAVROMATI M, Caironi V, Saiji E, Vargas MI, et al
     Langerhans cell histiocytosis of the suprasellar region: diagnosis based on thyroid cytology.
     Eur Thyroid J. 2024;13:e240011.
     PubMed     Abstract available
     
     
     
181. URSEM SR, Boelen A, Bruinstroop E, Elders PJM, et al
     A systematic review of subclinical hyperthyroidism guidelines: a remarkable range of recommendations.
     Eur Thyroid J. 2024;13:e240036.
     PubMed     Abstract available
     
     
     
182. DEMARTIN S, Constantinescu SM, Poppe KG, Maiter D, et al
     Long-term hypothyroidism in patients started on levothyroxine during pregnancy.
     Eur Thyroid J. 2024;13:e240051.
     PubMed     Abstract available
     
     
     
183. DE VINCENTIS S, Loiacono S, Zanni E, Sueri R, et al
     Subacute thyroiditis in the SARS-CoV-2 era: a multicentre prospective study.
     Eur Thyroid J. 2024;13:e240083.
     PubMed     Abstract available
     
     
     April 2024
184. BARRETO MCA, Treistman N, Cavalcante LBCP, Bulzico D, et al
     Serum anti-Mullerian hormone is lower in patients with multiple radioiodine dose for treatment of pediatric thyroid cancer.
     Eur Thyroid J. 2024;13:e230252.
     PubMed     Abstract available
     
     
     
185. PITICCHIO T, Russ G, Radzina M, Frasca F, et al
     Head-to-head comparison of American, European, and Asian TIRADSs in thyroid nodule assessment: systematic review and meta-analysis.
     Eur Thyroid J. 2024;13:e230242.
     PubMed     Abstract available
     
     
     
186. KOSTOPOULOS G, Effraimidis G
     Epidemiology, prognosis, and challenges in the management of hyperthyroidism-related atrial fibrillation.
     Eur Thyroid J. 2024;13:e230254.
     PubMed     Abstract available
     
     
     
187. RIIS T, Bonnema SJ, Brix TH, Folkestad L, et al
     Hyperthyroidism and the risk of non-thyroid cancer: a Danish register-based long-term follow-up study.
     Eur Thyroid J. 2024;13:e230181.
     PubMed     Abstract available
     
     
     
188. MULLER I, Maioli S, Armenti M, Porcaro L, et al
     Alemtuzumab-induced thyroid eye disease successfully treated with a single low dose of rituximab.
     Eur Thyroid J. 2024;13:e230236.
     PubMed     Abstract available
     
     
     
189. JU SH, Ji YB, Song M, Lim JY, et al
     Feasibility of active surveillance in patients with clinically T1b papillary thyroid carcinoma
     Eur Thyroid J. 2024;13:e230258.
     PubMed     Abstract available
     
     
     
190. CROCE L, Beneventi F, Ripepi F, De Maggio I, et al
     Relationship between maternal obesity and first-trimester TSH in women with negative anti-TPO antibodies.
     Eur Thyroid J. 2024;13:e230213.
     PubMed     Abstract available
     
     
     February 2024
191. HOU S, Sun Y, Yang Z, Tang M, et al
     The diagnostic value of GICA used for intraoperative lymph node FNA-Tg measurement to evaluate thyroid cancer metastases.
     Eur Thyroid J. 2024;13:e230182.
     PubMed     Abstract available
     
     
     
192. HOLMBERG M, Malmgren H, Berglund PF, Johansson B, et al
     Psychiatric complications in Graves' disease.
     Eur Thyroid J. 2024;13:e230247.
     PubMed     Abstract available
     
     
     
193. GIANOUKAKIS AG, Choe JH, Bowles DW, Brose MS, et al
     Real-world practice patterns and outcomes for RAI-refractory differentiated thyroid cancer.
     Eur Thyroid J. 2024;13:e230039.
     PubMed     Abstract available
     
     
     
194. ZHANG H, Hu H, Wang Y, Duan X, et al
     Predicting glucocorticoid effectiveness in thyroid eye disease: combined value from serological lipid metabolism and an orbital MRI parameter.
     Eur Thyroid J. 2024;13:e230109.
     PubMed     Abstract available
     
     
     December 2023
195. MAVROMATI M, Saiji E, Demarchi MS, Lenoir V, et al
     Unnecessary thyroid surgery rate for suspicious nodule in the absence of molecular testing.
     Eur Thyroid J. 2023;12:e230114.
     PubMed     Abstract available
     
     
     
196. CHIANG PL, Luo SD, Chang YH, Chou CK, et al
     Radiofrequency ablation for thyroid Bethesda III nodules: preliminary results.
     Eur Thyroid J. 2023;12:e230105.
     PubMed     Abstract available
     
     
     
197. GAMBALE C, Prete A, Contartese L, Torregrossa L, et al
     Usefulness of second 131I treatment in biochemical persistent differentiated thyroid cancer patients.
     Eur Thyroid J. 2023;12:e230052.
     PubMed     Abstract available
     
     
     
198. ESZLINGER M, Stephenson A, Mirhadi S, Patyra K, et al
     Activation of mitogen-activated protein kinase signaling and development of papillary thyroid carcinoma in thyroid-stimulating hormone receptor D633H knockin mice.
     Eur Thyroid J. 2023;12:e230049.
     PubMed     Abstract available
     
     
     
199. JANSEN HI, van Haeringen M, Bouva MJ, den Elzen WPJ, et al
     Optimizing the Dutch newborn screening for congenital hypothyroidism by incorporating amino acids and acylcarnitines in a machine learning-based model.
     Eur Thyroid J. 2023;12:e230141.
     PubMed     Abstract available
     
     
     
200. WU L, Vaccarella S, Feng CY, Dal Maso L, et al
     Mortality among papillary thyroid cancer patients by detection route: a hospital-based retrospective cohort study.
     Eur Thyroid J. 2023;12:e230127.
     PubMed     Abstract available
     
     
     
201. RIIS KR, Larsen CB, Medici BR, Jensen CZ, et al
     Hypothyroid women have persistently higher oxidative stress compared to healthy controls.
     Eur Thyroid J. 2023;12:e230167.
     PubMed     Abstract available
     
     
     
202. WAN Z, Li Y, Dong X, Kang Y, et al
     Influence of metabolic syndrome and lifestyle factors on thyroid nodules in Chinese adult men: a cross-sectional study.
     Eur Thyroid J. 2023;12:e230168.
     PubMed     Abstract available
     
     
     
203. CONSTANTINESCU SM, Hospel J, Daumerie C, Alexopoulou O, et al
     Significance of thyroperoxidase and thyroglobulin antibodies in medically treated Graves' disease.
     Eur Thyroid J. 2023;12:e230193.
     PubMed     Abstract available
     
     
     
204. TSENG HH, Lin YB, Lin KY, Lin CH, et al
     A 20-year study of autoimmune polyendocrine syndrome type II and III in Taiwan.
     Eur Thyroid J. 2023;12:e230162.
     PubMed     Abstract available
     
     
     
205. ESZLINGER M, Stephenson A, Mirhadi S, Patyra K, et al
     Activation of mitogen-activated protein kinase signaling and development of papillary thyroid carcinoma in thyroid-stimulating hormone receptor D633H knockin mice.
     Eur Thyroid J. 2023;12:e230049.
     PubMed     Abstract available
     
     
     
206. CHIANG PL, Luo SD, Chang YH, Chou CK, et al
     Radiofrequency ablation for thyroid Bethesda III nodules: preliminary results.
     Eur Thyroid J. 2023;12:e230105.
     PubMed     Abstract available
     
     
     
207. KYRILLI A, Tacelli N, Russo L, Lebrun L, et al
     Autonomously functioning thyroid nodules present intermediate malignancy risk according to European Thyroid Imaging Reporting and Data System (EU-TIRADS) and yield indeterminate cytology results.
     Eur Thyroid J. 2023;12:e230135.
     PubMed     Abstract available
     
     
     
208. LEE YJ, Choi YH, Lim YH, Kim BN, et al
     Effects of iodine status on thyroid volume and goiter in children living in an iodine-replete area.
     Eur Thyroid J. 2023;12:e230219.
     PubMed     Abstract available
     
     
     
209. HUSTED L, Rodgaard-Hansen S, Lundgaard MH, Uldall Torp NM, et al
     Biochemical markers of renal function and maternal hypothyroidism in early pregnancy.
     Eur Thyroid J. 2023;12:e230157.
     PubMed     Abstract available
     
     
     
210. WON HR, Kim MG, Kim MS, Chang JW, et al
     Clinical factors for choosing active surveillance: an analysis of papillary thyroid microcarcinoma patients with recurrence.
     Eur Thyroid J. 2023;12:e230195.
     PubMed     Abstract available
     
     
     
211. BAHCECIOGLU AB, Gursoy A, Dizbay Sak S, Ilgan S, et al
     The sonographer's and pathologist's perspective of echogenic microfoci in papillary thyroid carcinoma.
     Eur Thyroid J. 2023;12:e230108.
     PubMed     Abstract available
     
     
     
212. JIA HY, Chen J, Zhai ZX, Fan WW, et al
     Characterization of thyroid metastasis from clear cell renal cell carcinoma on ultrasonography: a report of three cases and literature review.
     Eur Thyroid J. 2023;12:e230121.
     PubMed     Abstract available
     
     
     October 2023
213. DURANTE C, Hegedus L, Czarniecka A, Paschke R, et al
     2023 European Thyroid Association Clinical Practice Guidelines for thyroid nodule management.
     Eur Thyroid J. 2023;12:e230067.
     PubMed     Abstract available
     
     
     
214. PINAR-GUTIERREZ A, Romero-Lluch AR, Duenas-Disotuar S, de Lara-Rodriguez I, et al
     Bone metastases from differentiated thyroid cancer: characteristics and prognostic factors in a multicenter series.
     Eur Thyroid J. 2023;12:e230086.
     PubMed     Abstract available
     
     
     
215. FU J, Fan Z, He L, Liu Q, et al
     Circadian clock disruption in autoimmune thyroiditis.
     Eur Thyroid J. 2023;12:e230035.
     PubMed     Abstract available
     
     
     
216. URSEM SR, Boelen A, Hillebrand JJ, den Elzen WPJ, et al
     How low can we (reliably) go? A method comparison of thyroid-stimulating hormone assays with a focus on low concentrations.
     Eur Thyroid J. 2023;12:e230123.
     PubMed     Abstract available
     
     
     
217. MANSO J, Censi S, Clausi C, Piva I, et al
     Circulating miR-146a predicts glucocorticoid response in thyroid eye disease.
     Eur Thyroid J. 2023;12:e230083.
     PubMed     Abstract available
     
     
     August 2023
218. WU J, Hu X, Seal P, Amin P, et al
     Improvement in neck ultrasound report quality following the implementation of European Thyroid Association guidelines for postoperative cervical ultrasound for thyroid cancer follow-up, a prospective population study.
     Eur Thyroid J. 2023;12:e230110.
     PubMed     Abstract available
     
     
     
219. HALENKA M, Munteanu H, Obereigneru R, Dohnal R, et al
     Ethanol ablation of thyroid cysts in the young with a focus on efficacy and quality of life.
     Eur Thyroid J. 2023;12:e230085.
     PubMed     Abstract available
     
     
     
220. SOLDEVILA B, Velasco I, Munoz C, Diaz Y, et al
     Longitudinal trajectories of maternal TSH in healthy pregnant women in Catalonia.
     Eur Thyroid J. 2023;12:e230016.
     PubMed     Abstract available
     
     
     
221. CAPDEVILA J, Deandreis D, Durante C, Leboulleux S, et al
     Use of lenvatinib in the treatment of radioiodine-refractory differentiated thyroid cancer: a multidisciplinary perspective for daily practice.
     Eur Thyroid J. 2023;12:e230068.
     PubMed     Abstract available
     
     
     
222. CAMPI I, Dell'Acqua M, Stellaria Grassi E, Cristina Vigone M, et al
     Unusual causes of hyperthyrotropinemia and differential diagnosis of primary hypothyroidism: a revised diagnostic flowchart.
     Eur Thyroid J. 2023;12:e230012.
     PubMed     Abstract available
     
     
     
223. PERROS P, Hegedus L
     Teprotumumab in thyroid eye disease: wonder drug or great divider?
     Eur Thyroid J. 2023;12:e230043.
     PubMed     Abstract available
     
     
     
224. JU N, Hou L, Song H, Qiu Z, et al
     TSH >/=30 mU/L may not be necessary for successful 131I remnant ablation in patients with differentiated thyroid cancer.
     Eur Thyroid J. 2023;12:e220219.
     PubMed     Abstract available
     
     
     July 2023
225. NILSSON JN, Siikanen J, Condello V, Jatta K, et al
     Iodine avidity in papillary and poorly differentiated thyroid cancer is predicted by immunohistochemical and molecular work-up.
     Eur Thyroid J. 2023;12:e230099.
     PubMed     Abstract available
     
     
     
226. MO C, Chen H, Zhang Q, Guo Y, et al
     Central hyperthyroidism combined with Graves' disease: case series and review of the literature.
     Eur Thyroid J. 2023;12:e220223.
     PubMed     Abstract available
     
     
     
227. BENABDELKAMEL H, Jaber MA, Dahabiyeh LA, Masood A, et al
     Metabolomic profile of patients on levothyroxine treatment for hypothyroidism.
     Eur Thyroid J. 2023;12:e230062.
     PubMed     Abstract available
     
     
     
228. BOELEN A, Zwaveling-Soonawala N, Heijboer AC, van Trotsenburg ASP, et al
     Neonatal screening for primary and central congenital hypothyroidism: is it time to go Dutch?
     Eur Thyroid J. 2023;12:e230041.
     PubMed     Abstract available
     
     
     
229. DAL MASO L, Pierannunzio D, Francisci S, De Paoli A, et al
     Trends in radioactive iodine treatment after total thyroidectomy in Italy, 2001-2018.
     Eur Thyroid J. 2023;12:e230051.
     PubMed     Abstract available
     
     
     
230. SOARES MN, Borges-Canha M, Neves C, Neves JS, et al
     The role of Graves' disease in the development of thyroid nodules and thyroid cancer.
     Eur Thyroid J. 2023;12:e230055.
     PubMed     Abstract available
     
     
     
231. JOHANSSON B, Holmberg M, Skau S, Malmgren H, et al
     The relationship between mental fatigue, depression, and cognition in Graves' disease.
     Eur Thyroid J. 2023;12:e230040.
     PubMed     Abstract available
     
     
     
232. COLOMBO C, Ceruti D, De Leo S, Bilo G, et al
     Management of hypertension during lenvatinib for advanced thyroid cancer: a suggested diagnostic and therapeutic algorithm.
     Eur Thyroid J. 2023;12:e230047.
     PubMed     Abstract available
     
     
     June 2023
233. DIAS D, Damasio I, Marques P, Simoes H, et al
     Metastatic follicular thyroid cancer with a longstanding responsiveness to gemcitabine plus oxaliplatin.
     Eur Thyroid J. 2023;12:e220227.
     PubMed     Abstract available
     
     
     
234. KARA C, Mammadova J, Abur U, Gumuskaptan C, et al
     Genetic testing can change diagnosis and treatment in children with congenital hypothyroidism.
     Eur Thyroid J. 2023;12:e220212.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Diseases of the Thyroid is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum